Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myeloma

Nature cancer

Klara Kropivsek, Paul Kachel, Sandra Goetze, …, Bernd Wollscheid, Markus G Manz, Berend Snijder

• DOI: 10.1038/s43018-023-00544-9
• PMID: 37081258
• PMCID: PMC10212768